195 related articles for article (PubMed ID: 1661054)
1. [Values of atrial natriuretic peptide (ANP) and cyclic guanosine monophosphate (cGMP) in cardioversion].
Lechleitner P; Genser N; Hauptlorenz S; Putensen C; Mitterschiffthaler G; Artner-Dworzak E; Puschendorf B; Dienstl F
Z Kardiol; 1991 Sep; 80(9):574-9. PubMed ID: 1661054
[TBL] [Abstract][Full Text] [Related]
2. Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: a clinical, echocardiographic and hormonal study.
Wozakowska-Kapłon B; Opolski G
Int J Cardiol; 2004 Aug; 96(2):171-6. PubMed ID: 15262030
[TBL] [Abstract][Full Text] [Related]
3. [Acute reduction of increased atrial natriuretic peptide level and cyclic guanosine monophosphate in patients with chronic heart failure caused by beta-adrenergic stimulation with dopexamine hydrochloride. Correlation with hemodynamic parameters].
Stangl K; Baumann G; Weil J; Gerzer R; Kerscher M; Blömer H
Z Kardiol; 1990 Jun; 79(6):417-23. PubMed ID: 1974099
[TBL] [Abstract][Full Text] [Related]
4. Atrial natriuretic peptide before and after cardioversion of persistent atrial fibrillation.
Wozakowska-Kapłon B; Opolski G; Janion M
Kardiol Pol; 2003 Apr; 58(4):255-63. PubMed ID: 14517556
[TBL] [Abstract][Full Text] [Related]
5. Atrial natriuretic peptide response to cardioversion of atrial flutter and fibrillation and role of associated heart failure.
Mookherjee S; Anderson G; Smulyan H; Vardan S
Am J Cardiol; 1991 Feb; 67(5):377-80. PubMed ID: 1825258
[TBL] [Abstract][Full Text] [Related]
6. Decreased plasma brain natriuretic peptide levels after a successful maze procedure.
Watanabe M; Murakami M; Furukawa H; Nakahara H; Tanaka H; Sunamori M
J Heart Valve Dis; 2003 May; 12(3):287-91. PubMed ID: 12803326
[TBL] [Abstract][Full Text] [Related]
7. Increased plasma cyclic guanosine monophosphate concentrations in children with high levels of circulating atrial natriuretic peptide.
Weil J; Gerzer R; Strom T; Lang RE; Döhlemann C; Knorr D; Bidlingmaier F
Pediatrics; 1987 Oct; 80(4):545-8. PubMed ID: 2821478
[TBL] [Abstract][Full Text] [Related]
8. Plasma concentrations of atrial and brain natriuretic peptides and cyclic guanosine monophosphate in response to dobutamine infusion in patients with surgically repaired tetralogy of fallot.
Hayabuchi Y; Matsuoka S; Kuroda Y
Pediatr Cardiol; 1999; 20(5):343-50. PubMed ID: 10441688
[TBL] [Abstract][Full Text] [Related]
9. [Atrial natriuretic factor in acute atrial hyperkinetic arrhythmia and chronic atrial fibrillo-flutter].
Fontana F; Spagnolo N; Capelli M; Bernardi P
G Ital Cardiol; 1989 May; 19(5):417-27. PubMed ID: 2527775
[TBL] [Abstract][Full Text] [Related]
10. Alternations in atrial natriuretic peptide release after DC cardioversion of non-valvular chronic atrial fibrillation.
Arakawa M; Miwa H; Noda T; Ito Y; Kambara K; Kagawa K; Nishigaki K; Kano A; Hirakawa S
Eur Heart J; 1995 Jul; 16(7):977-85. PubMed ID: 7498215
[TBL] [Abstract][Full Text] [Related]
11. Natriuretic peptide response to dynamic exercise in patients with atrial fibrillation.
Engelmann MD; Niemann L; Kanstrup IL; Skagen K; Godtfredsen J
Int J Cardiol; 2005 Oct; 105(1):31-9. PubMed ID: 16207542
[TBL] [Abstract][Full Text] [Related]
12. Effect of atrial fibrillation on hematopoietic progenitor cells: a novel pathophysiological role of the atrial natriuretic peptide?
Goette A; Jentsch-Ullrich K; Lendeckel U; Röcken C; Agbaria M; Auricchio A; Mohren M; Franke A; Klein HU
Circulation; 2003 Nov; 108(20):2446-9. PubMed ID: 14610014
[TBL] [Abstract][Full Text] [Related]
13. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
[TBL] [Abstract][Full Text] [Related]
14. Acute effects of beta-adrenergic stimulation with dobutamine on the plasma levels of atrial natriuretic peptide and cyclic guanosine monophosphate in patients with chronic heart failure.
Stangl K; Baumann G; Gerzer R; Weil J
Eur Heart J; 1991 Aug; 12(8):917-23. PubMed ID: 1655438
[TBL] [Abstract][Full Text] [Related]
15. Plasma concentrations of natriuretic peptides in patients on hemodialysis.
Takahashi M; Nagake Y; Ichikawa H; Kawabata K; Nakazono H; Hirata K; Ogura T; Makino H
Res Commun Mol Pathol Pharmacol; 1996 Apr; 92(1):19-30. PubMed ID: 8733825
[TBL] [Abstract][Full Text] [Related]
16. Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels.
Nakajima K; Onishi K; Dohi K; Tanabe M; Kurita T; Yamanaka T; Ito M; Isaka N; Nobori T; Nakano T
Int J Cardiol; 2005 Oct; 104(3):332-7. PubMed ID: 16186065
[TBL] [Abstract][Full Text] [Related]
17. Role of natriuretic peptides in cGMP production in fetal cardiac bypass.
Heeb EA; Baker RS; Lam C; Basu M; Lubbers W; Duffy JY; Eghtesady P
Ann Thorac Surg; 2009 Mar; 87(3):841-7. PubMed ID: 19231402
[TBL] [Abstract][Full Text] [Related]
18. [The influence of electrical cardioversion on left ventricular systolic function, left atrial size, ANP levels and enzymatic activity of CPK and CD-MB in serum of patients with paroxysmal atrial fibrillation].
Spring A; Kosmala W; Mysiak A
Przegl Lek; 1997; 54(9):585-90. PubMed ID: 9501676
[TBL] [Abstract][Full Text] [Related]
19. Atrial natriuretic peptide and cyclic guanosine monophosphate plasma concentrations in patients with thyrotoxicosis and atrial fibrillation. Effect of short-term methimazole therapy.
Czekalski S; Widecka K; Gozdzik J; Ciechanowski K; Krzyzanowska-Swiniarska B; Gromniak E; Gruszczynska M
J Endocrinol Invest; 1994 May; 17(5):341-6. PubMed ID: 8077618
[TBL] [Abstract][Full Text] [Related]
20. Plasma cGMP level as a marker of the hydration state in renal replacement therapy.
Lauster F; Heim JM; Drummer C; Fülle HJ; Gerzer R; Schiffl H
Kidney Int Suppl; 1993 Jun; 41():S57-9. PubMed ID: 8391608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
